The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors
Elena Campione,1 Evelin Jasmine Paternò,2 Eleonora Candi,3,4 Mattia Falconi,5 Gaetana Costanza,2 Laura Diluvio,1 Alessandro Terrinoni,4 Luca Bianchi,1 Augusto Orlandi2,6,7 1Department of Dermatology, 2Department of Biomedicine and Prevention, 3Department of Experimental Medicine and Surg...
Main Authors: | Campione E, Paternò EJ, Candi E, Falconi M, Costanza G, Diluvio L, Terrinoni A, Bianchi L, Orlandi A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-10-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | https://www.dovepress.com/the-relevance-of-piroxicam-for-the-prevention-and-treatment-of-nonmela-peer-reviewed-article-DDDT |
Similar Items
-
Nonmelanoma skin cancer
by: Venura Samarasinghe, et al.
Published: (2012-01-01) -
Nonmelanoma Skin Cancers: Embryologically Relevant Sites and UV Exposure
by: Giovanni Nicoletti, MD, FEBoPRAS, et al.
Published: (2020-04-01) -
Effects of topical 0.8% piroxicam and 50+ sunscreen filters on actinic keratosis in hypertensive patients treated with or without photosensitizing diuretic drugs: an observational cohort study
by: Mazzilli S, et al.
Published: (2018-10-01) -
Nonmelanoma skin cancer on the rise
by: Uwe Wollina
Published: (2012-01-01) -
Nonmelanoma skin cancer in women
by: H. Heaton, MD, et al.
Published: (2019-02-01)